Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 670


Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2.

Resende ATP, Martins CS, Bueno AC, Moreira AC, Foss-Freitas MC, de Castro M.

Clin Endocrinol (Oxf). 2019 Apr 6. doi: 10.1111/cen.13984. [Epub ahead of print]


Expression and activity of the cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 is tissue and species-specific.

Dammann C, Stapelfeld C, Maser E.

Chem Biol Interact. 2019 Apr 25;303:57-61. doi: 10.1016/j.cbi.2019.02.018. Epub 2019 Feb 21. Review.


Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial.

Cicero AFG, Sahebkar A, Fogacci F, Bove M, Giovannini M, Borghi C.

Eur J Nutr. 2019 Feb 22. doi: 10.1007/s00394-019-01916-7. [Epub ahead of print]


Role of 11β HSD 1, rs12086634, and rs846910 single-nucleotide polymorphisms in metabolic-related skin diseases: a clinical, biochemical, and genetic study.

Farag AGA, Badr EA, Eltorgoman AMA, Assar MF, Elshafey EN, Tayel NR, Aboutaleb HE.

Clin Cosmet Investig Dermatol. 2019 Jan 23;12:91-102. doi: 10.2147/CCID.S193156. eCollection 2019.


11β Hydroxysteroid dehydrogenase - 1 activity in type 2 diabetes mellitus: a comparative study.

Shukla R, Basu AK, Mandal B, Mukhopadhyay P, Maity A, Chakraborty S, Devrabhai PK.

BMC Endocr Disord. 2019 Jan 24;19(1):15. doi: 10.1186/s12902-019-0344-9.


Systemic, but not local, low-grade endotoxinemia increases plasma sCD163 independently of the cortisol response.

Bach E, Møller N, Jørgensen JOL, Buhl M, Møller HJ.

Endocr Connect. 2019 Feb 1;8(2):95-99. doi: 10.1530/EC-18-0554.


Metabolic syndrome and endocrine status in HIV-infected transwomen.

Pommier JD, Laouénan C, Michard F, Papot E, Urios P, Boutten A, Peytavin G, Ghander C, Lariven S, Castanedo G, Moho D, Landman R, Phung B, Perez E, Julia Z, Descamps D, Roland-Nicaise P, Le Gac S, Yazdanpanah Y, Guibourdenche J, Yeni P.

AIDS. 2019 Apr 1;33(5):855-865. doi: 10.1097/QAD.0000000000002152.


Autoimmune Diseases in Patients with Cushing's Syndrome after Resolution of Hypercortisolism: Case Reports and Literature Review.

Petramala L, Olmati F, Conforti MG, Concistré A, Bisogni V, Alfieri N, Iannucci G, de Toma G, Letizia C.

Int J Endocrinol. 2018 Dec 18;2018:1464967. doi: 10.1155/2018/1464967. eCollection 2018.


[Cardiovascular and metabolic impact of glucocorticoid substitution therapy in patients with Addison's disease].

Salah DB, Charfi N, Elleuch M, Kacem FH, Rekik N, Mnif M, Mnif F, Abid M.

Pan Afr Med J. 2018 Aug 6;30:251. doi: 10.11604/pamj.2018.30.251.12546. eCollection 2018. French.


Evaluation of the hypothalamic-pituitary-adrenal axis in a case series of familial partial lipodystrophy.

Elias CP, Antunes DE, Coelho MS, de Lima CL, Rassi N, de Melo APM, Amato AA.

Diabetol Metab Syndr. 2019 Jan 3;11:1. doi: 10.1186/s13098-018-0396-4. eCollection 2019.


Medical Correlates of Chronic Multisymptom Illness in Gulf War Veterans.

Blanchard M, Molina-Vicenty HD, Stein PK, Li X, Karlinsky J, Alpern R, Reda DJ, Toomey R.

Am J Med. 2019 Apr;132(4):510-518. doi: 10.1016/j.amjmed.2018.11.045. Epub 2018 Dec 18.


Associations of Dietary Patterns and Metabolic-Hormone Profiles with Breast Cancer Risk: A Case-Control Study.

Krusinska B, Wadolowska L, Slowinska MA, Biernacki M, Drozdowski M, Chadzynski T.

Nutrients. 2018 Dec 19;10(12). pii: E2013. doi: 10.3390/nu10122013.


Depressive symptoms are associated with higher morning plasma cortisol in primary care subjects.

Capponi V, Carrasco C, Macchiavello S, Undurraga J, Campino C, Carvajal C, Gomez T, Weiss C, Aedo I, Vecchiola A, Allende F, Solari S, Fardella C, Baudrand R.

Neuro Endocrinol Lett. 2018 Oct;39(4):288-293.


Fructose at the crossroads of the metabolic syndrome and obesity epidemics.

Mortera RR, Bains Y, Gugliucci A.

Front Biosci (Landmark Ed). 2019 Jan 1;24:186-211.


Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?

Moraes AB, Cavalari EMR, de Paula MP, Arruda M, Curi DSC, Leitão RA, de Mendonça LMC, Farias MLF, Madeira M, Vieira Neto L.

J Endocrinol Invest. 2018 Nov 21. doi: 10.1007/s40618-018-0985-y. [Epub ahead of print]


Metabolic Syndrome as a Predictor of Adrenal Functional Status: A Discriminant Multivariate Analysis Versus Logistic Regression Analysis.

Tsentidis C, Bampilis A, Ntova V, Fragkos D, Panos C, Limniati C, Kassi G.

Horm Metab Res. 2019 Jan;51(1):47-53. doi: 10.1055/a-0754-6464. Epub 2018 Nov 7.


No association between cardiometabolic risk and neural reactivity to acute psychosocial stress.

Lederbogen F, Ulshöfer E, Peifer A, Fehlner P, Bilek E, Streit F, Deuschle M, Tost H, Meyer-Lindenberg A.

Neuroimage Clin. 2018;20:1115-1122. doi: 10.1016/j.nicl.2018.10.018. Epub 2018 Oct 22.


Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters.

Akkus G, Evran M, Sert M, Tetiker T.

Endocr Metab Immune Disord Drug Targets. 2018 Oct 9. doi: 10.2174/1871530318666181009112042. [Epub ahead of print]


Serum Amyloid P and Endocrine Markers in a Cohort of Obese Children.

Anwer M, Iqbal MJ.

Indian J Endocrinol Metab. 2018 Sep-Oct;22(5):683-688. doi: 10.4103/ijem.IJEM_66_18.


Dysregulated Network of Immune, Endocrine and Metabolic Markers is Associated to More Severe Human Chronic Chagas Cardiomyopathy.

González F, Villar S, D'Attilio L, Leiva R, Marquez J, Lioi S, Beloscar J, Bottasso O, Perez AR.

Neuroimmunomodulation. 2018;25(3):119-128. doi: 10.1159/000491699. Epub 2018 Sep 25.

Supplemental Content

Loading ...
Support Center